ERYTHROPOIETIN® is used to treat anemia associated with chronic kidney disease, myelodysplasia, cancer chemotherapy. It contains recombinant human erythropoietin produced by recombinant DNA technology. Erythropoietin stimulates red blood cells production (erythropoiesis), protects them from apoptosis increases hemoglobin and hematocrit levels, improves blood supply of tissues and enhances the heart functioning.
GUARANTEE & EXPIRY DATE
100% Original from the Russian Binnopharm http://binnopharm.ru/.
All packs are air tight sealed and expire up to 01.2027.
The active substance of Erythropoietin is Epoetin beta - a synthetic analog of human erythropoietin and has the same biological activity as the endogenous hormone. By binding to the receptor on the red cell progenitor surface it activates JAK-STAT signaling pathways within the cytosol. This process stimulates the division and differentiation of committed erythroid progenitor cells by binding to the erythropoietin receptor, which induces the bone marrow to release reticulocytes into the blood stream, where they mature to erythrocytes.
PACKAGING & DOSAGE
Erythropoietin comes in the form of ampuls. Active substance: epoetin beta - 2000 IU/ml.
Erythropoietin is administered intravenously or subcutaneously.
Initial dose - 20IU per 1kg of body weight subcutaneously or 40IU per 1kg of body weight intravenously 3 times/week.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place. Do not exceed storage temperature of 2-8 degrees Celcius. Can be transported for up to two weeks at up to 23C degrees without loosing potency. Do not freeze. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about ERYTHROPOIETIN.
|The purpose of the medication||Blood and Circulatory Treatment|